Browsing Barts Cancer Institute by Subject "Testicular cancer"
Now showing items 1-2 of 2
-
Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patients.
(Elsevier Ltd., 2020-10-08)BACKGROUND: Radiotherapy and cisplatin-based combination chemotherapy are accepted standard-of-care treatments for metastatic seminoma with excellent survival outcomes but with established short- and long-term morbidity. ...